Metraipolis › archive › dc_cd4a32b3b031

Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine — Europe PMC PMID:40872337

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40872337
DOI
10.3390/pathogens14080827
License (as archived)
solo-consultazione
Archived
2026-11-10T11:05:27.108Z
SHA-256 of the archived text
98c575ba0cb593a3802b6459599ac7fb807556f1dac496fbcb0cbc040626c58a
Stable URL of this page
https://metraipolis.com/documento/dc_cd4a32b3b031

How to cite

Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine — Europe PMC PMID:40872337 — Europe PMC (en), https://europepmc.org/article/MED/40872337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd4a32b3b031 (Metraipolis archive dc_cd4a32b3b031, sha256 98c575ba0cb593a3802b6459599ac7fb807556f1dac496fbcb0cbc040626c58a)
BibTeX
@misc{dccd4a32b3b031,
  title = {Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine — Europe PMC PMID:40872337},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40872337},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd4a32b3b031; sha256 98c575ba0cb593a3802b6459599ac7fb807556f1dac496fbcb0cbc040626c58a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40872337. Agents can read the archived copy with the MCP tool read_document.